Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Mindset Pharma Inc.
  6. Summary
    MSET   CA60268M1023

MINDSET PHARMA INC.

(MSET)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Canadian National Stock E…
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
0.81(c) 0.84(c) 0.82(c) 0.79(c) 0.78(c) Last
410 658 89 441 283 065 384 240 131 613 Volume
-4.71% +3.70% -2.38% -3.66% -1.27% Change
More quotes
Estimated financial data (e)
Sales 2019
Net income 2019
Net Debt 2019
P/E ratio 2019
Yield 2019
Sales 2020 - - -
Net income 2020 -0,64 M -0,51 M -0,51 M
Net cash position 2020 0,54 M 0,43 M 0,43 M
P/E ratio 2020 -
Yield 2020 -
Capitalization 67,8 M 53,4 M 53,5 M
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees -
Free-Float -
More Financials
Company
Mindset Pharma Inc is a Canada-based psychedelic-based drug discovery company. The Company is focused on developing psychedelic compounds for treatment-resistant neurological and psychiatric disorders. 
More about the company
All news about MINDSET PHARMA INC.
09/23Mindset Pharma Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange T..
GL
09/20Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and ..
GL
09/20Mindset Pharma Inc. Announces Further Preclinical Results Demonstrating Strong Efficacy..
CI
09/14MINDSET PHARMA : Further Validates Lead Candidate as Next Generation Psilocybin Analog Thr..
MT
09/14MINDSET PHARMA : Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocyb..
AQ
09/09Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as I..
GL
09/07Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its ..
GL
09/07Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its ..
CI
09/02MINDSET PHARMA : to Participate in Upcoming Investor Conferences in September 2021
AQ
08/31Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic Analogs Demons..
GL
08/31Mindset Pharma Inc. Announces Next Generation Novel 5-Meo-Dmt Psychedelic Analogs Demon..
CI
08/26MINDSET PHARMA : Announces Preclinical Results Demonstrating Extended Duration of Action i..
AQ
08/26Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration of Action ..
CI
08/24MINDSET PHARMA : Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its..
AQ
08/24Mindset Pharma Inc. Files its New Provisional Patent Application with the United States..
CI
More news
News in other languages on MINDSET PHARMA INC.
09/20MINDSET PHARMA INC. : Mindset Pharma gibt weitere präklinische Ergebnisse bekannt, die sei..
09/20MINDSET PHARMA INC. : Mindset Pharma gibt weitere präklinische Ergebnisse bekannt, die sei..
09/14MINDSET PHARMA INC. : Mindset Pharma liefert durch Drug Discrimination Assay weiteren Nach..
09/14MINDSET PHARMA INC. : Mindset Pharma liefert durch Drug Discrimination Assay weiteren Nach..
09/09MINDSET PHARMA INC. : Mindset Pharma wählt therapieresistente Depressionen und Angstzustän..
More news
Chart MINDSET PHARMA INC.
Duration : Period :
Mindset Pharma Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
James Andre Charles Lanthier Chief Executive Officer
Arvin Ramos Chief Financial Officer
Richard J. Patricio Chairman
Joseph Araujo Director & Chief Science Officer
James Christopher Passin Director
Sector and Competitors
1st jan.Capi. (M$)
MINDSET PHARMA INC.-17.02%53
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353